Pipeline
The Science
About us
Investors
News

Hit enter to search or ESC to close

Alterity Therapeutics Investor Presentation

April 10, 2019 Kerry Rowe

Alterity Therapeutics Investor Presentation 10 April 2019

Post navigation

Alterity Therapeutics Launches to Asian Investors

Alterity Therapeutics presents at the American Academy of Neurology Annual Meeting

Related Posts

FDA End of Phase 2 Status Update

February 13, 2015

Life Biosciences LLC leads strategic investment of up to A$44.5 million in Prana

December 27, 2018

Prana Biotechnology 2014 Annual Report

October 1, 2014

Recent Posts

Presentation of New Biomarker Data at Scientific Congress
XBRL 30 June 2021 filed with the SEC
Alterity Announces New US Patent to Expand its Portfolio of Compounds for Neurodegenerative Diseases including Alzheimer’s and Parkinson’s
Quarterly Cash Flow Report
New Publication Demonstrates ATH434 is Neuroprotective

Recent Comments

Archives

Archives

Categories

ASX Announcements
Investor Announcement

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065